Secondary Pulmonary Alveolar Proteinosis Associated with Primary Myelofibrosis and Ruxolitinib Treatment: An Autopsy Case-Reference-Cited by-同舟云学术

Secondary Pulmonary Alveolar Proteinosis Associated with Primary Myelofibrosis and Ruxolitinib Treatment: An Autopsy Case

Published:2020-08-15 Issue:16 Volume:59 Page:2023-2028
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Sugiura Hiroyuki¹,Nishimori Hisakazu¹,Nishii Kazuya¹,Toji Tomohiro²,Fujii Keiko¹,Fujii Nobuharu¹,Matsuoka Ken-ichi¹,Nakata Koh³,Kiura Katsuyuki⁴,Maeda Yoshinobu¹

Affiliation:

1. Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan

2. Department of Pathology, Okayama University Hospital, Japan

3. Department of Bioscience Medical Research Center, Niigata University Medical & Dental Hospital, Japan

4. Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/16/59_4082-19/_pdf

Reference18 articles.

1. 1. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 349: 2527-2539, 2003.

2. 2. Trapnell BC, Nakata K, Bonella F, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers 5: 16, 2019.

3. 3. Verstovsek S, Mughal T, Vaddi K, Sarlis N. Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes. Int J Gen Med 7: 89-101, 2014.

4. 4. Cervantes F. How I treat myelofibrosis. Blood 124: 2635-2642, 2014.

5. 5. Salvator H, Berti E, Catherinot E, et al. Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation. Eur Respir J 51: 1701960, 2018.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib: A Case Report and Review of the Literature on Ruxolitinib-Associated Invasive Fungal Infections;Journal of Fungi;2024-03-31

2. Unusual cause of dyspnea in patient with Myelofibrosis: The Ruxolitinib lung;Respiratory Medicine Case Reports;2024

3. ASSOCIATION OF RUXOLITINIB WITH PULMONARY ALVEOLAR PROTEINOSIS: A CASE REPORT;CHEST;2023-10

4. Pulmonary alveolar proteinosis – current and future therapeutical strategies;Current Opinion in Pulmonary Medicine;2023-06-28

5. Sirolimus-induced secondary pulmonary alveolar proteinosis;Respiratory Medicine Case Reports;2022